000 | 01670 a2200457 4500 | ||
---|---|---|---|
005 | 20250518091514.0 | ||
264 | 0 | _c20201229 | |
008 | 202012s 0 0 eng d | ||
022 | _a1347-7439 | ||
024 | 7 |
_a10.1292/jvms.19-0450 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSayed, Noha | |
245 | 0 | 0 |
_aEffect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes. _h[electronic resource] |
260 |
_bThe Journal of veterinary medical science _cApr 2020 |
||
300 |
_a467-474 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xanalysis |
650 | 0 | 4 |
_aBenzhydryl Compounds _xpharmacology |
650 | 0 | 4 |
_aBody Weight _xdrug effects |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aGlucosides _xpharmacology |
650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
650 | 0 | 4 |
_aHyperglycemia _xdrug therapy |
650 | 0 | 4 |
_aHypertriglyceridemia _xdrug therapy |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aInsulin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xpharmacology |
700 | 1 | _aAbdalla, Osama | |
700 | 1 | _aKilany, Omnia | |
700 | 1 | _aDessouki, Amina | |
700 | 1 | _aYoshida, Toshinori | |
700 | 1 | _aSasaki, Kazuaki | |
700 | 1 | _aShimoda, Minoru | |
773 | 0 |
_tThe Journal of veterinary medical science _gvol. 82 _gno. 4 _gp. 467-474 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1292/jvms.19-0450 _zAvailable from publisher's website |
999 |
_c30731630 _d30731630 |